CD4 and neoplasm: Based on these findings, the tumor growth suppression observed in B16F10-mock tumors during CD4+ T cell depletion experiments may be primarily attributed to the removal of suppressive CD4+ T cells, including Foxp3+CD25+ Tregs, which may have enhanced CD8+ T cell-mediated anti-tumor immunity.